Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 2.96B 2.18B 2024-03
Aceragen USD 19M 3M 2023-03
Agios Pharmaceuticals USD 1.68B 434M 2024-03
Alnylam Pharmaceuticals USD 18.47B 5.56B 2024-03
Amgen USD 148.35B 5.79B 2024-03
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Biogen USD 31.4B 6.09B 2024-03
BioMarin Pharmaceutical USD 15.87B 2.29B 2024-03
Bluebird Bio USD 244M 19M 2024-03
Bristol-Myers Squibb USD 105.66B 1.26B 2024-03
Eli Lilly USD 731.69B 178.32B 2024-03
Exelixis USD 7.26B 205M 2024-03
Gilead Sciences USD 90.93B 10.01B 2024-03
Incyte USD 12.89B 1.18B 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Lumos Pharma USD 26M 1000K 2023-09
Merck USD 314.33B 38.07B 2024-03
Moderna USD 40.08B 2.16B 2024-03
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Pfizer USD 155.51B 7.05B 2024-03
PTC Therapeutics USD 2.22B 145M 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Ultragenyx Pharmaceutical USD 3.77B 153M 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



Incyte Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.